International Journal of Phytomedicine and Phytotherapy
Table 1 Glucose Levels and Concomitant Prescription (Rx) Treatments of Type 2 Diabetic Patients at Baseline and Following Daily Oral Administration of GlucoMedix®
Patient | Age | Sex | Glucose (mg/dl) | Rx Treatments | Glucose (mg/dl) | Rx Treatments | Glucose (mg/dl) |
|---|---|---|---|---|---|---|---|
at Baseline | at Baseline | on GlucoMedix | on GlucoMedix | Reduction (Ave.) | |||
S1 | 53 | F | 175–200 | Glibenclamide, Met. | 130–145 | none | 50 |
S2 | 50 | F | 180–200 | Vildagliptin | 110–130 | none | 70 |
R1 | 53 | M | 127 | none | 85–105 | none + diet | 32 |
100–120 | none | 17 | |||||
O1 | 59 | M | 200–270 | Glibenclamide, Met. | 121 | Glibenclamide, Met. | 114 |
R2 | 54 | M | 130–165 | none | 78–116 | none | 50 |
R3 | 65 | F | > 150 | Insulin, Metformin | < 100 | Insulin | > 50 |
< 140 | Insulin (half dose) | > 10 |